IDE705

About IDEAYA Biosciences

IDEAYA Biosciences is committed to discovering and developing transformative precision oncology therapies by integrating biomarker discovery with targeted therapeutics. The company leverages its expertise in synthetic lethality—an emerging class of targets that exploits cancer-specific genetic vulnerabilities—to create a therapeutic window. Its most advanced programs are in clinical development with key collaborations from Pfizer, Gilead, and GSK, positioning IDEAYA at the forefront of next-generation, biomarker-driven cancer treatments.

Therapeutic Areas